The Isoflavone Genistein Inhibits Proliferation and Increases Histamine Content in Human Leukemic Mast Cells

Allergy and Asthma Proceedings

Volumn 24, Issue 5, 2003, Pages 373-377

  Alexandrakis, Michael G ^b   Kyriakou, Despina S ^b   Kempuraj, Duraisamy ^a   Huang, Man ^a   Boucher, William ^a   Seretakis, Dimitris ^b   Theoharides, Theoharis C ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GENISTEIN; HISTAMINE; ISOFLAVONE DERIVATIVE;

ARTICLE; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; LEUKEMIA CELL; MAST CELL;

CELL CULTURE TECHNIQUES; CELL DIVISION; GENISTEIN; GROWTH INHIBITORS; HISTAMINE RELEASE; HUMANS; LEUKEMIA, MAST-CELL; MAST CELLS;

EID: 0242606437     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Metcalfe DD, Baram D, and Mekori YA. Mast cells. Physiol Rev 77:1033-1079, 1997.
2. Theoharides TC. The mast cell: a neuroimmunoendocrine master player. Int J Tissue React 18:1-21, 1996.
3. Serafin WE, and Austen KF. Mediators of immediate hypersensitivity reactions. N Engl J Med 317:30-34, 1987.
4. Galli SJ. New concepts about the mast cell. N Engl J Med 328:257-265, 1993.
5. Grabbe J, Welker P, Möller A, et al. Comparative cytokine release from human monocytes, monocyte-derived immature mast cells and a human mast cell line (HMC-1). J Invest Dermatol 103:504-508, 1994.
6. Church MK, and Levi-Schaffer F. The human mast cell. J Allergy Clin Immunol 99:155-160, 1997.
7. Stead RH, Dixon MF, Bramwell NH, et al. Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology 97:575-585, 1989.
8. Theoharides TC, Kempuraj D, and Sant GR. Mast cell involvement in interstitial cystitis: a review of human and experimental evidence. Urology 57:47-55, 2001.
9. Theoharides TC. Mast cells and stress - a psychoneuroimmunological perspective. J Clin Psychopharmacol 22:103-108, 2002.
10. Middleton E Jr, Kandaswami C, and Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52:673-751, 2000.
11. Miksicek RJ. Commonly occurring plant flavonoids have estrogenic activity. Mol Pharmacol 44:37-43, 1993.
12. Ferriola PC, Cody V, and Middleton E. Protein kinase inhibition by plant flavonoids, kinetic mechanisms, and structure-activity relationships. Biochem Pharmacol 38:1617-1624, 1989.
13. Spinozzi F, Pagliacci MC, Migliorati G, et al. The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkat T-leukemia cells. Leuk Res 18:431-439, 1994.
14. Bergamaschi G, Rosti V, Danova M, et al. Inhibitors of tyrosine phosphorylation induce apoptosis in human leukemic cell lines. Leukemia 7:2012-2018, 1993.
15. Traganos F, Ardelt B, Halko N, et al. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells. Cancer Res 52:6200-6208, 1992.
16. Constantinou A, Kiguchi K, and Huberman E. Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein. Cancer Res 50:2618-2624, 1990.
17. Pepper MS, Aktas E, Breit S, et al. Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res 57:2916-2921, 1997.
18. Li Y, Bhuiyan M, Mohammad RM, et al. Induction of apoptosis in breast cancer cells by TPA. Oncogene 17:2915-2920, 1998.
19. Alhasan SA, Ensley JF, and Sarkar FH. Genistein induced molecular changes in a squamous cell carcinoma of the head and neck cell line. Int J Oncol 16:333-338, 2000.
20. Davis JN, Singh B, Bhuiyan M, et al. Genistein-induced upregulation of p21WAF1, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells. Nutr Cancer 32:123-131, 1998.
21. Honma Y, Okabe-Kado J, Kasukabe T, et al. Inhibition of abl oncogene tyrosine kinase induces erythroid differentiation of human myelogenous leukemia K562 cells. Jpn J Cancer Res 81:1132-1136, 1990.
22. Alexandrakis M, Singh L, Boucher W, et al. Differential effect of flavonoids on inhibition of secretion and accumulation of secretory granules in rat basophilic leukemia cells. Int J Immunopharmacol 21:379-390, 1999.
23. Theoharides TC, Alexandrakis M, Kempuraj D, et al. Anti-inflammatory actions of flavonoids and structural requirements for new design. Int J Immunopathol Pharmacol 14:119-127, 2001.
24. Butterfield JH, Weiler D, Dewald G, et al. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 12:345-355, 1988.
25. Nilsson G, Blom T, Kusche-Gullberg M, et al. Phenotypic characterization of the human mast-cell line HMC-1. Scand J Immunol 39:489-498, 1994.
26. Selvan RS, Butterfield JH, and Krangel MS. Expression of multiple chemokine genes by a human mast cell leukemia. J Biol Chem 269:13893-13898, 1994.
27. Rimm EB, Katan MB, Ascherio A, et al. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann Intern Med 125:384-389, 1996.
28. Lian F, Bhuiyan M, Li YW, et al. Genistein-induced G2-M arrest, p21WAF1 upregulation, and apoptosis in a non-small-cell lung cancer cell line. Nutr Cancer 31:184-191, 1998.
29. Le Marchand L, Murphy SP, Hankin JH, et al. Intake of flavonoids and lung cancer. J Natl Cancer Inst 92:154-160, 2000.
30. McCabe MJ, and Orrenius S. Genistein induces apoptosis in immature human thymocytes by inhibiting topoisomerase II. Biochem Biophys Res Commun 194:944-950, 1993.
31. Markovits J, Linassier C, Fosse P, et al. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res 49:5111-5117, 1989.
32. Hirano T, Gotoh M and Oka K. Natural flavonoids and lignans are potent cytostatic agents against human leukemic HL-60 cells. Life Sci 55:1061-1069, 1994.
33. Jin Z, and MacDonald RS. Soy isoflavones increase latency of spontaneous mammary tumors in mice. J Nutr 132:3186-3190, 2002.
34. Katdare M, Osborne M, and Telang NT. Soy isoflavone genistein modulates cell cycle progression and induces apoptosis in HER-2/neu oncogene expressing human breast epithelial cells. Int J Oncol 21: 809-815, 2002.
35. Pearce FL, Befus AD, and Bienenstock J. Effect of quercetin and other flavonoids on antigen-induced histamine secretion from rat intestinal mast cells. J Allergy Clin Immunol 73:819-823, 1984.
36. Nagai S, Kitani S, Hirai K, et al. Pharmacological study of stem-cell-factor-induced mast cell histamine release with kinase inhibitors. Biochem Biophys Res Commun 208:576-581, 1995.
37. Wong WS, Tsang F, Li H, et al. Effects of inhibitors of the tyrosine kinase signaling cascade on an in vitro model of allergic airways. Asian Pac J Allergy Immunol 17:229-237, 1999.
38. Suzuki H, Takei M, Yanagida M, et al. Early and late events in FcεRI signal transduction in human cultured mast cells. J Immunol 159: 5881-5888, 1997.
39. Iwagoe H, Kohrogi H, Fujii K, et al. Inhibitory effect of tyrosine kinase inhibitors on antigen-induced tracheal contraction and histamine release in guinea pigs. Int Arch Allergy Immunol 111:291-298, 1996.
40. Columbo M, Horowitz EM, Kagey-Sobokta A, et al. Substance activates the release of histamine from human skin mast cells through a pertussis toxin-sensitive and protein kinase C-dependent mechanism. Clin Immunol Immunopathol 81:68-73, 1996.
41. Gruber BL, Marchese MJ, and Kew R. Angiogenic factors stimulate mast-cell migration. Blood 86:2488-2493, 1995.
42. Theoharides TC, Wang L, Pang X, et al. Cloning and cellular localization of the rat mast cell 78kD protein phosphorylated in response to the mast cell "stabilizer" cromolyn. J Pharmacol Exp Ther 294: 810-821, 2000.